Yongchao Chu

2.4k total citations · 1 hit paper
34 papers, 1.7k citations indexed

About

Yongchao Chu is a scholar working on Biomedical Engineering, Oncology and Molecular Biology. According to data from OpenAlex, Yongchao Chu has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Yongchao Chu's work include Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (8 papers) and Immune cells in cancer (6 papers). Yongchao Chu is often cited by papers focused on Nanoplatforms for cancer theranostics (13 papers), Nanoparticle-Based Drug Delivery (8 papers) and Immune cells in cancer (6 papers). Yongchao Chu collaborates with scholars based in China, South Korea and United Kingdom. Yongchao Chu's co-authors include Tao Sun, Peixin Liu, Hongyi Chen, Yiwen Zhang, Wenxi Zhou, Chen Jiang, Qin Guo, Chao Li, Hongjie Mu and Kaoxiang Sun and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Yongchao Chu

33 papers receiving 1.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment

2020 356 citations Wenxi Zhou, Yu Zhou et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongchao Chu China	21	755	521	347	339	327	34	1.7k
Neha N. Parayath United States	19	927 1.2×	555 1.1×	457 1.3×	620 1.8×	386 1.2×	29	1.8k
Peixin Liu China	22	791 1.0×	541 1.0×	263 0.8×	352 1.0×	328 1.0×	57	2.1k
Ibane Abasolo Spain	28	1.1k 1.4×	469 0.9×	309 0.9×	109 0.3×	521 1.6×	83	2.1k
Ying‐Li Luo China	22	1.1k 1.5×	625 1.2×	256 0.7×	440 1.3×	407 1.2×	37	1.9k
Davoud Ahmadvand Iran	25	877 1.2×	520 1.0×	416 1.2×	449 1.3×	475 1.5×	68	1.9k
Dongyoon Kim South Korea	22	675 0.9×	459 0.9×	199 0.6×	305 0.9×	313 1.0×	53	1.6k
Zhiting Cao China	21	1.1k 1.5×	887 1.7×	290 0.8×	236 0.7×	823 2.5×	27	2.1k
Sandro Matosevic United States	24	833 1.1×	462 0.9×	879 2.5×	977 2.9×	312 1.0×	47	2.4k
Chao Wan China	23	784 1.0×	765 1.5×	420 1.2×	486 1.4×	254 0.8×	74	2.0k
Joshua C. Doloff United States	19	824 1.1×	392 0.8×	283 0.8×	445 1.3×	208 0.6×	40	1.7k

Countries citing papers authored by Yongchao Chu

Since Specialization

Citations

This map shows the geographic impact of Yongchao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongchao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongchao Chu more than expected).

Fields of papers citing papers by Yongchao Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongchao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongchao Chu. The network helps show where Yongchao Chu may publish in the future.

Co-authorship network of co-authors of Yongchao Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongchao Chu. A scholar is included among the top collaborators of Yongchao Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongchao Chu. Yongchao Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Yanan, Hao Chen, Jianwei Guo, et al.. (2025). Cetuximab-Immunoliposomes Loaded with TGF-β1 siRNA for the Targeting Therapy of NSCLC: Design, and In Vitro and In Vivo Evaluation. International Journal of Molecular Sciences. 26(3). 1196–1196. 1 indexed citations

Tian, Yu, Yan Zhang, Yanqiu Li, et al.. (2025). RDYH58 functional exosomes targeting myofibroblasts loaded with siFKBP10 for inhibition of collagen biosynthesis and secretion of IPF. Acta Pharmaceutica Sinica B. 15(12). 6681–6697.

Chu, Yongchao, Boyu Su, Yifan Luo, et al.. (2023). Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness. Molecular Pharmaceutics. 20(3). 1591–1598. 3 indexed citations

Zhao, Zhenhao, Chufeng Li, Yiwen Zhang, et al.. (2023). Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases. Bioactive Materials. 27. 474–487. 12 indexed citations

Zhao, Xiaoyan, Chenglin Zhang, Yongchao Chu, et al.. (2023). A New HEK293 Cell with CR2 Region of E1A Gene Deletion Prevents the Emergence of Replication-Competent Adenovirus. Cancers. 15(24). 5713–5713. 2 indexed citations

Chu, Yongchao, et al.. (2022). Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol. Pharmaceutics. 14(2). 414–414. 5 indexed citations

Zhao, Zhenhao, Yujie Zhang, Chao Li, et al.. (2022). Microenvironment-tailored micelles restrain carcinoma-astrocyte crosstalk for brain metastasis. Journal of Controlled Release. 349. 520–532. 19 indexed citations

Chen, Hongyi, Qin Guo, Yongchao Chu, et al.. (2022). Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Biomaterials. 287. 121599–121599. 61 indexed citations

Chu, Yongchao, Yifan Luo, Boyu Su, et al.. (2022). A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy. Acta Pharmaceutica Sinica B. 13(1). 298–314. 34 indexed citations

10.

Zhang, Zhe, Chenglin Zhang, Na Zhang, et al.. (2022). An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition. Molecular Therapy — Oncolytics. 26. 105–119. 21 indexed citations

11.

Zhou, Zheng, Keying Li, Yongchao Chu, et al.. (2022). ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy. Acta Pharmaceutica Sinica B. 13(3). 1246–1261. 17 indexed citations

12.

Chu, Yongchao, et al.. (2022). The Effect of Education Model in Physical Education on Student Learning Behavior. Frontiers in Psychology. 13. 944507–944507. 16 indexed citations

13.

Liu, Peixin, Tongyu Zhang, Qinjun Chen, et al.. (2021). Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation. Advanced Materials. 33(26). e2100746–e2100746. 115 indexed citations

14.

Zhou, Wenxi, Han Y. H. Chen, Yu Zhou, et al.. (2021). Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Biomaterials. 280. 121306–121306. 67 indexed citations

15.

Zhou, Wenxi, Yu Zhou, Xinli Chen, et al.. (2020). Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 268. 120546–120546. 356 indexed citations breakdown →

16.

Sun, Tao, Guang‐Ping Zhang, Zhongyuan Guo, et al.. (2020). Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic. Journal of Controlled Release. 321. 483–496. 36 indexed citations

17.

Sun, Tao, Xiaofei Wang, Kai Zhang, et al.. (2020). Carry-On Nitric-Oxide Luggage for Enhanced Chemotherapeutic Efficacy. Nano Letters. 20(7). 5275–5283. 29 indexed citations

18.

Wang, Na, Jiwei Wang, Zhe Zhang, et al.. (2020). A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer. Molecular Therapy — Oncolytics. 20. 71–81. 19 indexed citations

19.

Chu, Yongchao, Ning Chen, Huajun Yu, et al.. (2017). Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles. International Journal of Nanomedicine. Volume 12. 1353–1368. 44 indexed citations

20.

Yu, Huajun, Xuemei Zhang, Hongjie Mu, et al.. (2016). Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate. Pharmaceutical Research. 34(1). 121–135. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact